Skip to main content

Soligenix, Inc.

SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000812796

No open-market purchases or sales by Soligenix, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $369.6K in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Soligenix, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of SNGX: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders1523+8
Shares189.7K1.39M+1.20M (+632.4%)
Value$248.2K$1.61M+$1.36M (+549.2%)

New holders (12)

Institutions that held Soligenix, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to SNGX in Q3 2025
InstitutionSharesValue% of portfolio
Armistice Capital, LLC708,000$821.3K0.03%
DRW Securities, LLC171,422$198.8K0.01%
Two Sigma Investments, LP87,646$101.7K0.00%
Sabby Management, LLC81,000$94.0K0.49%
Renaissance Technologies LLC72,900$84.6K0.00%
HRT Financial LP54,669$63.0K0.00%
Vanguard Group Inc52,522$60.9K0.00%
Virtu Financial LLC50,864$59.0K0.00%
Banco BTG Pactual S.A.46,372$53.8K0.01%
Squarepoint Ops LLC12,232$14.2K0.00%
IFP Advisors, Inc50$580.00%
BlackRock, Inc.1$10.00%

Sold out (4)

Institutions that held Soligenix, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of SNGX in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Connective Capital Management, LLC119,481$156.5K
Citadel Advisors LLC15,160$19.9K
Raymond James Financial Inc1$1
Royal Bank of Canada250$0